Paige.AI

Paige is a pioneering company in the field of digital pathology, leveraging artificial intelligence (AI) to revolutionize cancer diagnosis and treatment. The company serves pathologists, clinicians, and researchers by providing advanced insights derived from decades of data diagnosed by world-renowned cancer experts. Operating in the healthcare and biotechnology market, Paige utilizes a business model centered around AI-powered clinical decision support systems. These systems are designed to augment the capabilities of medical professionals, offering efficiencies and reproducibility in data analysis. Paige generates revenue through the sale of its AI-driven software solutions and services, which include a proprietary dataset, robust machine learning algorithms, and a unique scanner-neutral slide viewer. The company's AIRI infrastructure, boasting GPU performance of more than 10 petaFLOPS, enables the training of models at an unprecedented scale. This infrastructure supports the development of clinical-grade algorithms that provide powerful new insights for pathology and pharmaceutical development teams. Paige's AI suite is FDA 510k cleared for primary diagnosis of digital pathology slides, underscoring its clinical reliability and effectiveness.

Keywords: AI, digital pathology, cancer diagnosis, clinical insights, machine learning, healthcare, biotechnology, clinical decision support, FDA clearance, biomarker discovery.